Raynaud’s Syndrome News

Botox was found to be effective in the treatment of severe Raynaud’s phenomenon, according to the results of a study.

Patients with antisynthetase syndrome who test positive for anti-citrullinated peptide / protein antibodies may also have rheumatoid arthritis and may not respond well to conventional treatments, according to research published in Medicine.

According to data presented at the European League Against Rheumatism Annual European Congress of Rheumatology, temporary work disability may be reduced with early intervention for musculoskeletal diseases.

The use of laser speckle contrast imaging may be a useful tool in assessing Raynaud’s phenomenon in patients with systemic sclerosis, but neither objective nor subjective measurements distinguished which disease was primary, according to study results.

Patients at a single rheumatology tertiary center in the United Kingdom gave correct responses about half of the time, on average, to questions about clinical trial details, but respondents who had higher knowledge about clinical trials were more willing to participate in research, according to recently published study findings.

Some patients with Raynaud’s phenomenon met 2013 American College of Rheumatology/European League Against Rheumatism criteria for systemic sclerosis but did not meet 1980 American College of Rheumatology criteria, according to researchers at the Yonsei University College of Medicine in Seoul, South Korea.

Women with diffuse systemic sclerosis had a significantly longer time to diagnosis when compared with men with diffuse systemic sclerorosis after the onset of Raynaud’s phenomenon, although the difference was small, according to study results.